Treatment of hyperhidrosis

      Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief, Warren R. Heymann, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology.
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Connolly M.
        • de Berker D.
        Management of primary hyperhidrosis: a summary of the different treatment modalities.
        Am J Clin Dermatol. 2003; 4: 681-697
        • Campanati A.
        • Penna L.
        • Guzzo T.
        • Menotta L.
        • Silvestri B.
        • Lagalla G.
        • et al.
        Quality-of-life in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
        Clin Ther. 2003; 25: 298-308
        • Heckman M.
        • Ceballos-Baumann A.O.
        • Plewig G.
        Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
        N Engl J Med. 2001; 344: 488-493
        • Naumann M.
        • Lowe N.J.
        Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomized, parallel group, double blind, placebo controlled trial.
        BMJ. 2001; 323: 596-599
        • Lowe P.L.
        • Cerdan-Sanz S.
        • Lowe N.J.
        Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
        Dermatol Surg. 2003; 29: 545-548
        • Heckman M.
        • Teichman B.
        • Pause B.
        • Plewig G.
        Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A.
        Arch Dermatol. 2003; 139: 57-59
      1. Ravitskiy L, Heymann WR. Botulin toxin-induced resolution of axillary granular parakeratosis. Skinmed (in press)

        • Field L.
        Re: Botox for a lifetime or tumescent axillary liposuction and curettage once.
        Dermatol Surg. 2003; 29: 793-794
        • Rompel R.
        • Scholz S.
        Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.
        J Eur Acad Dermatol Venereol. 2001; 15: 207-211